Year Item Type Full Text

Article

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial. (2022) Manno, Daniela; Bangura, Agnes; Baiden, Frank; Kamara, Abu Bakarr; Ayieko, Philip; Kallon, Joseph; Foster, Julie; Conteh, Musa; Connor, Nicholas Edward; Koroma, Bockarie; Njie, Yusupha; Borboh, Paul; Keshinro, Babajide; Lawal, Bolarinde Joseph; Kroma, Mattu Tehtor; Otieno, Godfrey Tuda; Deen, Abdul Tejan; Choi, Edward Man-Lik; Balami, Ahmed Dahiru; Gaddah, Auguste; McLean, Chelsea; Luhn, Kerstin; Adetola, Hammed Hassan; Deen, Gibrilla Fadlu; Samai, Mohamed; Lowe, Brett; Robinson, Cynthia; Leigh, Bailah; Greenwood, Brian; Watson-Jones, Deborah

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen. (2023) Manno, Daniela; Patterson, Catriona; Drammeh, Abdoulie; Tetteh, Kevin; Kroma, Mattu Tehtor; Otieno, Godfrey Tuda; Lawal, Bolarinde Joseph; Soremekun, Seyi; Ayieko, Philip; Gaddah, Auguste; Kamara, Abu Bakarr; Baiden, Frank; Afolabi, Muhammed Olanrewaju; Tindanbil, Daniel; Owusu-Kyei, Kwabena; Ishola, David; Deen, Gibrilla Fadlu; Keshinro, Babajide; Njie, Yusupha; Samai, Mohamed; Lowe, Brett; Robinson, Cynthia; Leigh, Bailah; Drakeley, Chris; Greenwood, Brian; Watson-Jones, Deborah